Immediate Impact
3 standout
Citing Papers
Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches
2023 Standout
Current therapy and drug resistance in metastatic castration-resistant prostate cancer
2023 Standout
Works of Isabelle Rieger being referenced
A phase 3 trial with a 2x2 factorial design of abiraterone acetate plus prednisone and/or local radiotherapy in men with de novo metastatic castration-sensitive prostate cancer (mCSPC): First results of PEACE-1.
2021
LBA5 A phase III trial with a 2x2 factorial design in men with de novo metastatic castration-sensitive prostate cancer: Overall survival with abiraterone acetate plus prednisone in PEACE-1
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Isabelle Rieger | 62 | 21 | 12 | 29 | 26 | 7 | 90 | |
| Ihor Sawczuk | 82 | 17 | 4 | 14 | 56 | 7 | 113 | |
| Cristina Zuliani | 24 | 22 | 23 | 12 | 39 | 9 | 169 | |
| Anna Ratiu | 56 | 14 | 27 | 33 | 7 | 171 | ||
| Louis Marie Dourthe | 101 | 57 | 3 | 30 | 87 | 5 | 172 | |
| Antonio Verde | 114 | 37 | 3 | 25 | 62 | 12 | 181 | |
| Martin Russell | 66 | 30 | 1 | 26 | 32 | 9 | 109 | |
| Delphine Gourcerol | 47 | 77 | 9 | 26 | 6 | 195 | ||
| M. Button | 129 | 82 | 2 | 41 | 20 | 12 | 174 | |
| Yen-Chuan Ou | 65 | 35 | 11 | 17 | 22 | 6 | 116 | |
| T Onishi | 85 | 16 | 17 | 14 | 8 | 96 |
All Works
Loading papers...